Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | MMP2 | P08253 | 4/20 | 0.98 |
| ▸ | MMP9 | P14780 | 4/20 | 0.98 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.98 |
| ▸ | PRKCG | P05129 | 3/20 | 0.98 |
| ▸ | PRKCB | P05771 | 3/20 | 0.98 |
| ▸ | PRKCA | P17252 | 3/20 | 0.98 |
| ▸ | PRKCH | P24723 | 3/20 | 0.98 |
| ▸ | PRKCI | P41743 | 3/20 | 0.98 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.98 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.98 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.98 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.98 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.98 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.94 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.67 |
| ▸ | BACE1 | P56817 | 4/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procyanidin B2 SCHEMBL15142352 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL718738 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL18685718 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL14626386 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL14339427 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL23251016 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL14413656 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL20661403 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL22043665 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL13285131 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4408187-B1 | PROANTHOCYANIDINS (CONDENSED TANNINS) AS NUTRIENT FOR HONEY BEES | Apix Biosciences (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4696145-A2 | PROANTHOCYANIDINS (CONDENSED TANNINS) AS NUTRIENT FOR HONEY BEES | APIX BIOSCIENCES (BE) | 2026-02-18 | — | — | EP | claimed |
| CN-118914413-B | Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi | 海南省农业科学院三亚研究院(海南省实验动物研究中心) | 2024-12-03 | — | — | CN | claimed |
| CN-118914413-A | Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi | 海南省农业科学院三亚研究院(海南省实验动物研究中心) | 2024-11-08 | — | — | CN | claimed |
| CN-118858503-A | Method for constructing characteristic spectrum of chinaberry bark water extract and identification method thereof | 广东一方制药有限公司 | 2024-10-29 | — | — | CN | claimed |
| WO-2024175614-A1 | STABLE LIQUID FORMULATIONS COMPRISING (6S)-5-METHYLTETRAHYDROFOLIC ACID OR SALTS THEREOF | MERCK PATENT GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| WO-2024171994-A1 | COMPOSITION, COMPOSITION FOR INHIBITING PLATELET AGGREGATION, COMPOSITION FOR AMELIORATING HYPERTENSION, AND COMPOSITION FOR IMPROVING SKIN TEXTURE | 株式会社東洋新薬 | 2024-08-22 | — | — | WO | claimed |
| CN-117969715-A | Qualitative and quantitative detection method for bioactive substances with different structures in agricultural products | 上海市农业科学院 | 2024-05-03 | — | — | CN | claimed |
| US-20240115678-A1 | PERSONALIZED MULTIDISCIPLINARY CANCER THERAPY | VELTMEYER JAMES (US) | 2024-04-11 | — | — | US | claimed |
| WO-2024026505-A2 | DISRUPTION OF TELOCYTE ACTIVITY | PATEL AMIT (US) | 2024-02-01 | — | — | WO | claimed |
| EP-2331111-A1 | ANTIOXIDANT AND PHYSICAL PERFORMANCE EFFECTS OF A GRAPE EXTRACT | Naturex S.A. (FR) | 2011-06-15 | — | — | EP | claimed |
| EP-2322923-A2 | Method for procyanidin analysis | Suntory Holdings Limited (JP) | 2011-05-18 | — | — | EP | claimed |
| CN-102028773-A | Method for identifying radix rosae gigantea extract | MEDICAL COLLEGE OF THE CHINESE PEOPLE S ARMED POLICE FORCES | 2011-04-27 | — | — | CN | claimed |
| WO-2010053918-A1 | COMPOSITE CONTAINING COLLAGEN AND ELASTIN AS A DERMAL EXPANDER AND TISSUE FILLER | HANCOCK JAFFE LABORATORIES, INC. (US) | 2010-05-14 | — | — | WO | claimed |
| WO-2010021935-A1 | ANTIOXIDANT AND PHYSICAL PERFORMANCE EFFECTS OF A GRAPE EXTRACT | NATUREX S.A. (FR) | 2010-02-25 | — | — | WO | claimed |
| US-20100047372-A1 | ANTIOXIDANT AND PHYSICAL PERFORMANCE EFFECTS OF A GRAPE EXTRACT | Naturex, S.A. | 2010-02-25 | — | — | US | claimed |
| EP-1388343-B1 | Use of a root extract from Rosa multiflora as antioxidant | EROMLIFE CO LTD (KR) | 2008-05-14 | — | — | EP | claimed |
| US-6858235-B2 | Antioxidant composition and method of preparation thereof | EROMLIFE CO. LTD. (KR) | 2005-02-22 | — | — | US | claimed |
| US-20040028758-A1 | Antioxidant composition and method of preparation thereof | EROMLIFE CO., LTD. | 2004-02-12 | — | — | US | claimed |
| EP-1388343-A1 | Antioxidant composition and method of preparation thereof | Eromlife Co., Ltd. (KR) | 2004-02-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040028758-A1 | Antioxidant composition and method of preparation thereof | NOX4, GPX4, PRDX3 | SNCA 2736/4885HSD17B10 997/4885ALOX15 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.